a Relative staining intensity: staining of tissue relative to that of cells from a head and neck cancer cell line that expresses EGFR (886 cell line). a Time to progression. b Combined data for ...

Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) have a poor prognosis, particularly those whose disease has progressed on previous platinum ...

Cetuximab (Erbitux) plus chemotherapy showed higher progression-free survival (PFS) and overall survival (OS) for patients with metastatic colorectal cancer (mCRC), according to one study.

Combining encorafenib (Braftovi) and cetuximab (Erbitux; EC) with the chemotherapy regimen of fluorouracil, leucovorin, and irinotecan (FOLFIRI) was tolerable and showed promising antitumor activity ...

Progression-free survival of all 18 patients. Censored patients are indicated by hash marks. Credit: Oncotarget (2023). DOI: 10.18632/oncotarget.28470 ...

Subsequently, we topically administered cetuximab-800CW and performed high-definition white-light endoscopy (HD-WLE), narrow-band imaging, and NIR-FME in 15 patients with Barrett esophagus ...

Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer. ... The live/dead cell staining experiment showed that ...

Introduction. Therapeutic regimens for metastatic colorectal cancer (mCRC) include chemotherapy and targeted therapy. The chemotherapeutic drugs generally include fluorouracil, oxaliplatin, and ...

Compared with monotherapy, combining cetuximab with radioimmunotherapy significantly and synergistically reduced tumor growth and prolonged survival of mice in 2 of the subcutaneous and in the ...

They first generated cetuximab-resistant clones of the lung cancer-derived HCC827 cell line using a previously described method. In these cells, unlike in the parental HCC827 cells, cetuximab did ...

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma ... (DAKO, Carpinteria, CA). Primary antibody and detection reagent ...